Carisma Therapeutics
-
Doylestown’s Aprea Therapeutics Names Industry Veteran as Chief Medical Advisor
Doylestown-based Aprea Therapeutics has named Eugene Kennedy, MD, as chief medical advisor, adding a seasoned leader in oncology drug development to its executive team. Aprea…
-
Carisma Therapeutics Selects First Drug Candidate Under Moderna Partnership, Triggers $2M Payment
Philadelphia-based Carisma Therapeutics has chosen an experimental cell therapy that targets the most prevalent type of liver cancer as the first drug development candidate under…
-
7 Philadelphia-based Health Startups Selected to Participate in University City Science Center Capital Readiness Program
University City Science Center has selected 12 health tech startups for the third cohort of its Capital Readiness program, and seven have offices in Philadelphia,…
Founding Partners
Advertisement
Affiliate Partners
